Aubrey Manack Adams

4.0k total citations
91 papers, 2.7k citations indexed

About

Aubrey Manack Adams is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Aubrey Manack Adams has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Psychiatry and Mental health, 44 papers in Pathology and Forensic Medicine and 33 papers in Neurology. Recurrent topics in Aubrey Manack Adams's work include Migraine and Headache Studies (78 papers), Trigeminal Neuralgia and Treatments (35 papers) and Botulinum Toxin and Related Neurological Disorders (33 papers). Aubrey Manack Adams is often cited by papers focused on Migraine and Headache Studies (78 papers), Trigeminal Neuralgia and Treatments (35 papers) and Botulinum Toxin and Related Neurological Disorders (33 papers). Aubrey Manack Adams collaborates with scholars based in United States, Ireland and United Kingdom. Aubrey Manack Adams's co-authors include Richard B. Lipton, Dawn C. Buse, Michael L. Reed, Kristina M. Fanning, Andrew Blumenfeld, Mitchell F. Brin, Daniel Serrano, I Scher, David W. Dodick and Stephen D. Silberstein and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Aubrey Manack Adams

85 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aubrey Manack Adams United States	29	2.4k	1.4k	772	621	250	91	2.7k
Sepideh F. Varon United States	27	3.1k 1.3×	2.0k 1.4×	885 1.1×	510 0.8×	320 1.3×	38	3.6k
Todd D. Rozen United States	26	1.9k 0.8×	1.3k 0.9×	913 1.2×	547 0.9×	263 1.1×	124	2.4k
Andrew Blumenfeld United States	35	3.3k 1.4×	2.3k 1.6×	1.4k 1.9×	958 1.5×	476 1.9×	126	4.0k
Paola Torelli Italy	26	1.9k 0.8×	1.3k 0.9×	813 1.1×	390 0.6×	195 0.8×	135	2.4k
Dagny Holle Germany	29	1.9k 0.8×	1.3k 0.9×	868 1.1×	399 0.6×	205 0.8×	120	2.9k
Gian Camillo Manzoni Italy	30	2.9k 1.2×	1.9k 1.3×	1.3k 1.7×	379 0.6×	205 0.8×	121	3.4k
David Kudrow United States	26	2.5k 1.0×	1.8k 1.2×	1.1k 1.4×	275 0.4×	249 1.0×	65	2.8k
Derya Uludüz Türkiye	22	1.6k 0.7×	792 0.6×	434 0.6×	275 0.4×	244 1.0×	83	2.0k
Stephen D. Silberstein United States	28	2.9k 1.2×	1.7k 1.2×	1.1k 1.4×	237 0.4×	276 1.1×	58	3.2k
LJ Stovner Norway	27	2.1k 0.9×	1.2k 0.8×	789 1.0×	317 0.5×	288 1.2×	42	2.6k

Countries citing papers authored by Aubrey Manack Adams

Since Specialization

Citations

This map shows the geographic impact of Aubrey Manack Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aubrey Manack Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aubrey Manack Adams more than expected).

Fields of papers citing papers by Aubrey Manack Adams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aubrey Manack Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aubrey Manack Adams. The network helps show where Aubrey Manack Adams may publish in the future.

Co-authorship network of co-authors of Aubrey Manack Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Aubrey Manack Adams. A scholar is included among the top collaborators of Aubrey Manack Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aubrey Manack Adams. Aubrey Manack Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adams, Aubrey Manack, et al.. (2023). Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study. The Journal of Headache and Pain. 24(1). 102–102. 10 indexed citations

Blumenfeld, Andrew, Richard B. Lipton, Stephen D. Silberstein, et al.. (2023). Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review. Neurology and Therapy. 12(5). 1533–1551. 10 indexed citations

Brin, Mitchell F., Russell S. Kirby, Anne Slavotinek, et al.. (2023). Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment. Neurology. 101(2). e103–e113. 18 indexed citations

Lipton, Richard B., Michel Lantéri‐Minet, Élizabeth Leroux, et al.. (2023). Pre- and post-headache phases of migraine: multi-country results from the CaMEO – International Study. The Journal of Headache and Pain. 24(1). 151–151. 7 indexed citations

Adams, Aubrey Manack, et al.. (2022). Real-World Effectiveness of Ubrogepant for the Acute Treatment of Migraine When Used in Combination With an Anti-Calcitonin Gene–Related Peptide Monoclonal Antibody Preventive: Results From the COURAGE Study (P10-2.003). Neurology. 98(18_supplement). 3 indexed citations

Blumenfeld, Andrew, et al.. (2021). Real-World Evidence for Control of Patients With Chronic Migraine Who Received Calcitonin Gene–Related Peptide (CGRP) Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment (1426). Neurology. 96(15_supplement). 1 indexed citations

Hutchinson, Susan, Richard B. Lipton, Jessica Ailani, et al.. (2020). Characterization of Acute Prescription Migraine Medication Use. Mayo Clinic Proceedings. 95(4). 709–718. 21 indexed citations

Diener, Hans‐Christoph, David W. Dodick, Richard B. Lipton, et al.. (2020). Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis. SHILAP Revista de lepidopterología. 9(2). 683–694. 8 indexed citations

Francisco, Gerard E., Wolfgang H. Jost, Ganesh Bavikatte, et al.. (2020). Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE Study. PM&R. 12(11). 1120–1133. 17 indexed citations

10.

Buse, Dawn C., Stephanie J. Nahas, Todd J. Schwedt, et al.. (2020). Acute Treatment Management Gaps in People With Migraine: Results of the CaMEO Study (105). Neurology. 94(15_supplement). 1 indexed citations

11.

Buse, Dawn C., et al.. (2019). Life With Migraine, Effect on Relationships, Career and Finances, and Overall Health and Well-Being: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (S59.002). Neurology. 92(15_supplement).

12.

Young, William B., John F. Rothrock, Amelia Orejudos, et al.. (2019). Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study. The Journal of Headache and Pain. 20(1). 12–12. 19 indexed citations

13.

Adams, Aubrey Manack, Richard B. Lipton, Vincent T. Martin, et al.. (2018). The Relationship between Pain, Psychiatric, and Endocrine/Neurological Comorbidities of Migraine: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study (P3.124). Neurology. 90(15_supplement). 1 indexed citations

14.

Blumenfeld, Andrew, Stewart J. Tepper, Lawrence Robbins, Aubrey Manack Adams, & Stephen D. Silberstein. (2018). The Effects of OnabotulinumtoxinA Treatment on the Chronic Migraine Comorbidities of Sleep and Fatigue (P4.131). Neurology. 90(15_supplement). 1 indexed citations

15.

Ahmed, Fayyaz, Charly Gaul, Paolo Martelletti, Juan Carlos García‐Moncó, & Aubrey Manack Adams. (2018). Real-Life Use of OnabotulinumtoxinA for the Symptomatic Treatment of Chronic Migraine: The REPOSE Study (P4.150). Neurology. 90(15_supplement). 2 indexed citations

16.

Francisco, Gerard E., Daniel S. Bandari, Ganesh Bavikatte, et al.. (2017). The Adult Spasticity International Registry (ASPIRE) Study: 1-Year Results (P4.034). Neurology. 88(16_supplement). 1 indexed citations

17.

Blumenfeld, Andrew, Richard Stark, Aubrey Manack Adams, Amelia Orejudos, & Sheena K. Aurora. (2016). Efficacy and safety of onabotulinumtoxinA in an open-label study for the prophylactic treatment of chronic migraine in adult patients: Compel. Toxicon. 123. S7–S7. 5 indexed citations

18.

Buse, Dawn C., et al.. (2015). Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache‐Related Disability: Results From the American Migraine Prevalence and Prevention ( AMPP ) Study. Headache The Journal of Head and Face Pain. 55(6). 825–839. 14 indexed citations

19.

Charles, David, Charles H. Adler, Mark Stacy, et al.. (2014). Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). Journal of Neurology. 261(7). 1309–1319. 63 indexed citations

20.

Jankovic, Joseph, Charles H. Adler, David Charles, et al.. (2014). Primary results from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE). Journal of the Neurological Sciences. 349(1-2). 84–93. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact